Showing 5231-5240 of 21466 results for "".
- Amivantamab Plus Lazertinib in EGFR-Mutant Lung Cancer with CNS Metastaseshttps://reachmd.com/news/amivantamab-lazertinib-lung-cancer--cns-metastases/2487255/Key Takeaways The study included 20 patients with brain metastases and 21 with leptomeningeal disease after prior therapy. The primary endpoint was composite best overall response using RECIST 1.1 with RANO brain metastases or RANO leptomeningeal metas
- CANDIN Meets Primary Endpoint in Phase 3 Common Wart Trialhttps://reachmd.com/news/candin-meets-primary-endpoint-in-phase-3-common-wart-trial/2487261/Nielsen BioSciences announced positive topline findings from its Phase 3 trial evaluating CANDIN (Purified
- FDA Pilots AI for Near Real-Time Clinical Trial Monitoringhttps://reachmd.com/news/fda-pilots-ai-for-near-real-time-clinical-trial-monitoring/2487265/The U.S. Food and Drug Administration is testing the use of artificial intelligence and data science tools in real-time clinical trials as part of an effort to accelerate the development of new drug therapies. According to the agency, traditional clinical development can be slowed by
- Analysis: Pediatric Allergic Rhinitis Doubled in Japan Over 40 Yearshttps://reachmd.com/news/analysis-pediatric-allergic-rhinitis-doubled-in-japan-over-40-years/2487238/A 40-year epidemiologic analysis published in the World Allergy Organization Journal showed an increases in allergic rhinitis (AR), allergic conjunctivitis (AC), and Japanese cedar pollinosis (JCP) among school-aged children in western Japan, while rates of atopic dermatitis (AD) and bro
- RADIESSE Study Links Calcium Hydroxylapatite to ECM Regenerationhttps://reachmd.com/news/radiesse-study-links-calcium-hydroxylapatite-to-ecm-regeneration/2487241/Merz Aesthetics announced new data showing that RADIESSE may support regeneration of multiple extracellular matrix components, including collagen, elastin, decorin, and versican, in human skin.
- Neurophet, VHIR Launch MS MRI Validation Study for AQUA MShttps://reachmd.com/news/neurophet-vhir-launch-ms-mri-validation-study-for-aqua-ms/2487214/Key Takeaways Neurophet and VHIR announced a joint research collaboration focused on validating Neurophet AQUA MS for MRI-based multiple sclerosis lesion detection. VHIR will provide de-identified MRI scans and expert lesion labels, and the work will t
- TG Therapeutics Details Planned BRIUMVI Presentations for CMSC 2026https://reachmd.com/news/tg-therapeutics-details-planned-briumvi-presentations-for-cmsc-2026/2487215/Key Takeaways TG Therapeutics presented new data on BRIUMVI (ublituximab-xiiy) at the American Academy of Neurology (AAN) 2026 annual meeting focused on relapsing multiple sclerosis (RMS). The presentations included findings from the ENABLE Phase 4 obs
- PRONTO Trial Finds Mortality Drop With Procalcitonin Plus NEWS2https://reachmd.com/news/pronto-trial-finds-mortality-drop-with-procalcitonin-plus-news2/2487230/Key Takeaways Twenty-eight-day mortality in patients with suspected sepsis was lower in the procalcitonin-guided group than in the usual-care group. Intravenous antibiotic initiation at 3 hours was similar in the two groups. In the
- BGN4 Probiotic Trial Links Microbiome Shifts To Biomarker Changeshttps://reachmd.com/news/bgn4-probiotic-trial-links-microbiome-shifts-to-biomarker-changes/2487218/Key Takeaways BGN4 was not associated with significant changes in hs-CRP, BMI, or body fat percentage, but significant between-group differences were reported for zonulin, TNFα, and fasting insulin. Supplementation was associated with enrichment of Bac
- AI Quality Control Deployment Reshapes Whole-Slide Workflowhttps://reachmd.com/news/ai-quality-control-deployment-reshapes-whole-slide-workflow/2487222/Key Takeaways Automated QC sat downstream of image acquisition, using a staging area plus PathSync and the enterprise integration engine to route images to acceptance, rescan, or reprocessing under predefined thresholds. Feasibility testing covered 60